Katsunori Yanagihara - Infectious Diseases

Author Information

Katsunori Yanagihara is a distinguished researcher affiliated with the Department of Laboratory Medicine at Nagasaki University Hospital in Nagasaki, Japan. His work primarily focuses on infectious diseases, contributing significantly to the understanding and management of various infections. His affiliation with a renowned institution underlines his commitment to advancing medical research and public health.

Research Contributions

Katsunori Yanagihara has made substantial contributions to the field of infectious diseases, with a particular focus on pathogens and their implications in clinical settings. His recent work includes studies on the epidemiology and pathology of infectious diseases such as Aspergillosis, Enterococcus faecium, and Escherichia coli. He has also been actively involved in research concerning the COVID-19 pandemic, exploring aspects such as the evolution of the SARS-CoV-2 virus on cruise ships and the efficacy of treatments for mild COVID-19 pneumonia. Additionally, his research extends into antimicrobial resistance, organ transplantation, and the impact of oral health on pneumonia in elderly patients with dementia.

Aliases

Katsunori Yanagihara is also known by other names in academic publications, including K Yanagihara and K. Yanagihara. These aliases are used interchangeably across various research papers and articles.

Publication and Citation Metrics

Metric	Value
Total Citation Count	8175
H-index	46
Total Paper Count	636

Publications:

Serum Cytokines Usefulness for Understanding the Pathology in Allergic Bronchopulmonary Aspergillosis and Chronic Pulmonary Aspergillosis

DOI: 10.3390/jof8050436

Year: 2022

The interplay between community and hospital Enterococcus faecium clones within health-care settings: a genomic analysis

DOI: 10.1016/s2666-5247(21)00236-6

Year: 2022

Corrigendum: The Contribution of Serum Complement Component 3 Levels to 90-Day Mortality in Living Donor Liver Transplantation

DOI: 10.3389/fimmu.2022.870480

Year: 2022

Escherichia coli ST131 isolated from urological patients can acquire plasmid-mediated extended spectrum β-lactamase from other bacteria with high frequency.

DOI: 10.1111/iju.14845

Year: 2022

Unique Evolution of SARS-CoV-2 in the Second Large Cruise Ship Cluster in Japan

DOI: 10.3390/microorganisms10010099

Year: 2022

Epidemiology of Coronavirus Disease Outbreak among Crewmembers on Cruise Ship, Nagasaki City, Japan, April 2020

DOI: 10.3201/eid2709.204596

Year: 2021

Change in antimicrobial susceptibility of pathogens isolated from surgical site infections over the past decade in Japanese nation-wide surveillance study.

DOI: 10.1016/j.jiac.2021.03.010

Year: 2021

Assessment of oral health in elderly patients with dementia by measuring volatile sulfur compounds and its relationship with pneumonia development: A pilot study.

DOI: 10.1016/j.resinv.2021.08.006

Year: 2021

Efficacy of clarithromycin in patients with mild COVID-19 pneumonia not receiving oxygen administration: protocol for an exploratory, multicentre, open-label, randomised controlled trial (CAME COVID-19 study)

DOI: 10.1136/bmjopen-2021-053325

Year: 2021

P5‐28: Correlation of serum interleukin‐6 level and COVID‐19 severity on hospital admission and survival

DOI: 10.1111/resp.14150_235

Year: 2021

What Treatments are Available for Bacterial Infections?

What are the Key Factors in Resource Allocation?

How are DAAs used in combination therapies?

How Should Condoms Be Used Correctly?

How Can We Support the Global Fund?

What are the Strengths and Limitations?

How Do Epidemiologists Track Infectious Diseases?

How Do Viruses Cause Respiratory Symptoms?

What is Parasite DNA?

How is Herpes Diagnosed?

Partnered Content Networks

Relevant Topics